Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

For about 25 million Americans who suffer from obstructive sleep apnea, there are various effective treatments such as CPAP breathing machines, surgery, a dental mouthpiece and even an implantable pac ...

At Tom's Guide, our number one piece of sleep advice is to find the best mattress for your needs. But while we often ...

New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 478.78% and ...

The sleep apnea diagnostic systems market is expected to grow from US$ 4.81 billion in 2023 to US$ 9.27 billion by 2033, at a ...

1. Obesity drugs are only going to become more common. With the so-called Ozempic boom, consumers are more aware of these ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

Below are the recipients of the 2024 Shkreli Award, as decided by the Lown Institute.

Medical device maker Stryker said it has reached a deal to acquire Inari Medical for $80 per share in cash, representing an ...

With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.

The demand of this tailor-made equipment are spread across the world. The key manufacturers and exporters are based in US and ...